Copenhagen, Denmark

Vera Pinto Glenting

This inventor holds 3 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignee: Novo Nordisk A/s. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vera Pinto Glenting. Retrieved from https://idiyas.com/inventor/vera-pinto-glenting

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Vera Pinto Glenting: Pioneering Drug Delivery Devices

Introduction

Vera Pinto Glenting, a visionary inventor based in Copenhagen, Denmark, has made significant strides in the field of medical technology with her innovative contributions. With three patents to her name, she is dedicated to improving drug delivery systems to enhance patient care and streamline medical procedures.

Latest Patents

One of Vera's latest inventions is a multi-use drug delivery device designed for drugs with fewer preservatives. This device features a main portion that can be used multiple times in conjunction with a single-use flow conducting device. The innovative design includes an intermediate configuration that allows for an equalization of fluid pressure, effectively mitigating the risk of introducing microorganisms into the drug reservoir. This advancement is crucial for ensuring the safety and efficacy of drug delivery to subcutaneous tissues.

Another notable invention is the needle unit with a floating needle hub, which is specifically designed for use in pen injection devices. This needle unit provides improved functionality, ensuring that the needle shield and axially movable needle hub work seamlessly together, enhancing the user experience for patients requiring injections.

Career Highlights

Vera Pinto Glenting is affiliated with Novo Nordisk A/S, a leading global healthcare company that specializes in diabetes care and other chronic diseases. Her commitment to innovation and improving healthcare solutions is well-aligned with the mission of Novo Nordisk.

Collaborations

Throughout her career, Vera has collaborated with accomplished colleagues, including Henrik Bengtsson and Joern Drustrup. These partnerships enable the exchange of ideas and expertise, driving the development of cutting-edge technologies that benefit patients globally.

Conclusion

Vera Pinto Glenting is an inspiring figure in the field of medical innovation, with a strong focus on enhancing drug delivery methods. Her patents reflect her commitment to safety and efficiency in healthcare, establishing her as a key player in advancing medical technology. As she continues to innovate, her work will undoubtedly have a lasting impact on patient care and the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…